1 – 3 of 3
- show: 250
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
-
Mark
An orally active galectin-3 antagonist inhibits lung adenocarcinoma growth and augments response to PD-L1 blockade
(
- Contribution to journal › Article
- 2012
-
Mark
Regulation of Transforming Growth Factor-beta 1-driven Lung Fibrosis by Galectin-3
(
- Contribution to journal › Article
- 2008
-
Mark
Regulation of alternative macrophage activation by galectin-3
(
- Contribution to journal › Article